Trials / Completed
CompletedNCT03434249
Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic
Studio Clinico Randomizzato Per Valutare l'Efficacia Del Bifidobacterium BB-12® Nel Trattamento Delle Coliche Infantili
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- SOFAR S.p.A. · Industry
- Sex
- All
- Age
- 7 Weeks
- Healthy volunteers
- Not accepted
Summary
This is a single-center, randomized, double blind controlled study to investigate the effects of Bifidobacterium, BB-12® versus placebo in a study group of pediatric patients with infantile colic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Bifidobacterium, BB-12® (Bifidolactis Infant) | |
| DIETARY_SUPPLEMENT | Bifidolactis Infant Placebo |
Timeline
- Start date
- 2016-11-11
- Primary completion
- 2017-11-06
- Completion
- 2017-11-06
- First posted
- 2018-02-15
- Last updated
- 2020-01-23
- Results posted
- 2020-01-23
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03434249. Inclusion in this directory is not an endorsement.